Comparative Analysis of Conventional Antibiotics and Next-Generation Alternatives in Combating Antibiotic Resistance: Why Static Drugs Cannot Outpace an Adaptive Genome
Journal of Youth Impact · 2026
DOI: 10.66245/jyi.v1.i3.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Youth Impact, 2026. Verfasst von George Moromoke Ugochukwu.
Abstract (Originalsprache)
Antibiotic resistance poses a threat to decades of clinical improvement and modern medicine, as antibiotics serve as the backbone of modern medicine, driven by a fundamental evolutionary mismatch: static antibiotics cannot outpace the rapidly adapting bacterial genome. Also, the development pipeline is stalled; antibiotic production carries a 90 percent failure risk, takes 10 to 15 years, and costs an estimated 1 billion dollars, so many major pharmaceutical companies have opted out of production. To address this crisis, this paper evaluates three next-generation alternatives, CRISPR-Cas9, bacteriophage therapy, and antimicrobial peptides (AMPs), against three criteria: genomic adaptability, evolutionary trade-offs, and durability against mutations. Our analysis reveals that while CRISPR-Cas9 performs better in genomic adaptability, it faces limitations due to delivery challenges. Bacteriophages impose powerful evolutionary trade-offs on bacteria through antagonistic pleiotropy, but their narrow host range restricts broad use and makes them hyper-specific. AMPs exhibit high durability against target-site mutations but face significant toxicity and stability barriers. As a result, no single alternative can serve as a long-term monotherapy replacement for conventional antibiotics. Because each therapy addresses a different bacterial resistance, the future therapeutics for AMR treatment must pivot toward combinatorial approaches, such as CRISPR-armed phages.
Zitieren
APA
Ugochukwu, G. M. (2026). Comparative Analysis of Conventional Antibiotics and Next-Generation Alternatives in Combating Antibiotic Resistance: Why Static Drugs Cannot Outpace an Adaptive Genome. Journal of Youth Impact. https://doi.org/10.66245/jyi.v1.i3.002
Vancouver
Ugochukwu GM. Comparative Analysis of Conventional Antibiotics and Next-Generation Alternatives in Combating Antibiotic Resistance: Why Static Drugs Cannot Outpace an Adaptive Genome. Journal of Youth Impact. 2026. doi:10.66245/jyi.v1.i3.002
BibTeX
@article{Ugochukwu2026,
author = {Ugochukwu, George Moromoke},
title = {Comparative Analysis of Conventional Antibiotics and Next-Generation Alternatives in Combating Antibiotic Resistance: Why Static Drugs Cannot Outpace an Adaptive Genome},
journal = {Journal of Youth Impact},
year = {2026},
doi = {10.66245/jyi.v1.i3.002}
}
EUVIMED